Startups
Sound Biologics creates innovative technology to better serve patients through the development of treatments for cancer. We aspire to discover and progress therapies that will impact human health and reduce the cost of biotherapeutics.
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 3, 2022 | Sound Biologics Announces Presentations at ASCO 2022 Annual Meeting | PSB205/QL1706, a bifunctional anti-PD-1 and anti-CTLA-4 MabPair product, demonstrates anti-tumor effects with acceptable tolerability and manageable toxicity PSB205 demonstrated strong anti-tumor activities of the dual immune checkpoint blo... |
Reviews 0
FAQ about Sound Biologics
What has the press written about Sound Biologics?
Parsers VC has collected 2 articles mentioning Sound Biologics, among them “Sound Biologics Announces Presentations at ASCO 2022 Annual Meeting” (Jun 3, 2022).
Is Sound Biologics still active?
Yes, Sound Biologics is active; its latest activity on Parsers VC dates from Oct 16, 2024.